Skip to main content
OpenTrials

Clinical trial condition

Metabolic Dysfunction-Associated Steatotic Liver Disease

Explore clinical trials studying Metabolic Dysfunction-Associated Steatotic Liver Disease. Study availability and eligibility vary by location and protocol.

61 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Metabolic Dysfunction-Associated Steatotic Liver Disease trial results

Completed

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

NCT06482112

Conditions
Digestive System Diseases, Fatty Liver, Liver Disease, +5 more
Locations
  • The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 0 Chandler, Arizona, United States
  • The Institute for Liver Health II dba Arizona Liver Health - Peoria ( Site 0224) Peoria, Arizona, United States
  • Arizona Liver Health ( Site 0211) Tucson, Arizona, United States
  • Del Sol Research Management, LLC ( Site 0209) Tucson, Arizona, United States
View all 39 locations
View Trial Details
Completed

Antidiabetic Drugs for Steatotic Liver Disease

NCT03646292

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Disease, +19 more
Locations
  • Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea Seoul, South Korea
View Trial Details
Active, Not Recruiting

Effect of a GnRH Analog on Hepatic Steatosis

NCT06523530

Conditions
Digestive System Diseases, Endometriosis, Fatty Liver, +13 more
Locations
  • 424 General Military Hospital Thessaloniki, Greece
  • 1st Department of Obstetrics and Gynecology, School of Medicine, Aristotle University of Thessaloniki Thessaloniki, Greece
View Trial Details

Related conditions